Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05729347 · ClinicalTrials.gov registry record · NA

Treatment of Parental Anxiety Virtual Reality (VR)

A NA study of Anxiety and Virtual Reality, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
485
Enrollment target
1
Study location

NCT05729347 is a NA study of Anxiety and Virtual Reality that has completed, run by Stanford University. The registered enrollment target is 485 participants, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05729347, a NA study of Anxiety and Virtual Reality, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
485 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations

Interventions

  • BEHAVIORAL Virtual Reality headset with calming scenery

Study Locations (1)

California

  • Lucile Parkard Children's Hospital - Stanford

Trial Details

FieldValue
Enrollment Target 485 participants
Start Date 2023-06-01
Est. Completion 2025-10-13
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05729347

The ClinicalTrials.gov registry entry for NCT05729347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 485 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (10% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality headset with calming scenery is the first listed.

NCT05729347 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05729347 about?

NCT05729347 is a clinical study titled "Treatment of Parental Anxiety Virtual Reality (VR)". The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations

What is the current status of trial NCT05729347?

This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2023-06-01. Estimated completion is 2025-10-13.

What conditions does trial NCT05729347 study?

This clinical trial studies the following conditions: Anxiety, Virtual Reality, Parents.

What interventions are being tested in trial NCT05729347?

The interventions under investigation include: Virtual Reality headset with calming scenery (BEHAVIORAL).

Who is sponsoring clinical trial NCT05729347?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05729347 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.